Cas No.: | 1985605-59-1 |
Chemical Name: | (R)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-7-hydroxy-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione |
Synonyms: | Baloxavir; Baloxavir acid; BXA |
SMILES: | N12C=CC(=O)C(O)=C1C(=O)N1CCOC[C@]1([H])N2[C@@H]1C2=CC=C(F)C(F)=C2CSC2=CC=CC=C21 |
Formula: | C24H19F2N3O4S |
M.Wt: | 483.49 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Baloxavir is an anti-influenza agent extracted from patent WO 2017104691 A1. |
Target: | Influenza virus[1] |
References: | [1]. Shishido Takao, et al. Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug. WO 2017104691 A1. |